| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.032 | 0.5 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.5 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.5 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.052 | 0.5 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.055 | 0.5 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.2 | 0.5 |